NT5E and breast carcinoma: CD73 has been also identified as a target for pharmacotherapy strategies of breast cancer (Stagg et al., 2010), and it plays critical role during injury protection in the renal proximal tubule as well as in immune processes, such as inflammation (Antonioli et al., 2013; Sung et al., 2017).